Switch theme
Sign up to access all valuation multiples
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
1989
9.2K+
LTM Revenue $1.9B
LTM EBITDA $468M
$9.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Masimo has a last 12-month revenue (LTM) of $1.9B and a last 12-month EBITDA of $468M.
In the most recent fiscal year, Masimo achieved revenue of $2.1B and an EBITDA of -$159M.
Masimo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Masimo valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | XXX | $2.1B | XXX | XXX | XXX |
| Gross Profit | $1.1B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $468M | XXX | -$159M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | -8% | XXX | XXX | XXX |
| EBIT | $372M | XXX | $37.8M | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | -$85.4M | XXX | -$305M | XXX | XXX | XXX |
| Net Margin | -5% | XXX | -15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $588M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Masimo's stock price is $163.
Masimo has current market cap of $8.8B, and EV of $9.4B.
See Masimo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9.4B | $8.8B | XXX | XXX | XXX | XXX | $4.64 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Masimo has market cap of $8.8B and EV of $9.4B.
Masimo's trades at 4.5x EV/Revenue multiple, and -59.0x EV/EBITDA.
Equity research analysts estimate Masimo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Masimo has a P/E ratio of -103.2x.
See valuation multiples for Masimo and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.8B | XXX | $8.8B | XXX | XXX | XXX |
| EV (current) | $9.4B | XXX | $9.4B | XXX | XXX | XXX |
| EV/Revenue | 5.0x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBITDA | 20.0x | XXX | -59.0x | XXX | XXX | XXX |
| EV/EBIT | 25.2x | XXX | 247.7x | XXX | XXX | XXX |
| EV/Gross Profit | 8.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -103.2x | XXX | -28.9x | XXX | XXX | XXX |
| EV/FCF | 34.6x | XXX | 64.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMasimo's last 12 month revenue growth is -16%
Masimo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Masimo's rule of 40 is -4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Masimo's rule of X is -14% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Masimo and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -16% | XXX | -12% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | -8% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | -4% | XXX | -23% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -14% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Masimo acquired XXX companies to date.
Last acquisition by Masimo was XXXXXXXX, XXXXX XXXXX XXXXXX . Masimo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Masimo founded? | Masimo was founded in 1989. |
| Where is Masimo headquartered? | Masimo is headquartered in United States of America. |
| How many employees does Masimo have? | As of today, Masimo has 9.2K+ employees. |
| Who is the CEO of Masimo? | Masimo's CEO is Ms. Catherine M. Szyman. |
| Is Masimo publicy listed? | Yes, Masimo is a public company listed on NAS. |
| What is the stock symbol of Masimo? | Masimo trades under MASI ticker. |
| When did Masimo go public? | Masimo went public in 2007. |
| Who are competitors of Masimo? | Similar companies to Masimo include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Masimo? | Masimo's current market cap is $8.8B |
| What is the current revenue of Masimo? | Masimo's last 12 months revenue is $1.9B. |
| What is the current revenue growth of Masimo? | Masimo revenue growth (NTM/LTM) is -16%. |
| What is the current EV/Revenue multiple of Masimo? | Current revenue multiple of Masimo is 5.0x. |
| Is Masimo profitable? | Yes, Masimo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Masimo? | Masimo's last 12 months EBITDA is $468M. |
| What is Masimo's EBITDA margin? | Masimo's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Masimo? | Current EBITDA multiple of Masimo is 20.0x. |
| What is the current FCF of Masimo? | Masimo's last 12 months FCF is $271M. |
| What is Masimo's FCF margin? | Masimo's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Masimo? | Current FCF multiple of Masimo is 34.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
